Management of Hypercalcemia
Aggressive IV fluid resuscitation with normal saline followed by bisphosphonates (preferably zoledronic acid) is the cornerstone of hypercalcemia management, with treatment tailored to severity. 1
Classification of Hypercalcemia
- Mild: Total calcium <12 mg/dL
- Moderate: Total calcium 12.0-13.5 mg/dL
- Severe: Total calcium ≥14 mg/dL or ≥12 mg/dL with symptoms 1
Step-wise Treatment Approach
1. Initial Assessment
- Confirm hypercalcemia with albumin-corrected calcium calculation:
- Corrected calcium (mg/dL) = Total calcium (mg/dL) + 0.8 × [4 - Serum albumin (g/dL)] 1
- Essential laboratory tests:
- Intact parathyroid hormone (iPTH) - crucial to distinguish PTH-dependent from PTH-independent causes
- 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels
- Complete blood count, electrolytes, renal function 1
2. Treatment Based on Severity
For Severe Hypercalcemia (≥14 mg/dL or symptomatic)
Aggressive IV fluid resuscitation
Bisphosphonates
Additional Pharmacological Options
- Denosumab: 120 mg subcutaneously for patients with severe renal impairment or refractory cases 1
- Calcitonin: For immediate short-term management while waiting for bisphosphonates to take effect 1, 4
- Loop diuretics (e.g., furosemide): Only after adequate hydration to enhance calcium excretion 1
- Note: Recent evidence questions the additional benefit of furosemide beyond saline hydration alone 5
Dialysis
- Consider for severe hypercalcemia with renal failure or heart failure
- Calcium-free dialysate recommended 4
For Moderate Hypercalcemia (12.0-13.5 mg/dL)
- IV hydration with normal saline
- Consider bisphosphonates if symptomatic or if calcium levels don't respond to hydration 1, 6
For Mild Hypercalcemia (<12 mg/dL)
- Usually doesn't require acute intervention
- Treat underlying cause
- Ensure adequate hydration 6
3. Specific Scenarios
Hypercalcemia due to Granulomatous Disorders or Vitamin D Toxicity
Tumor Lysis Syndrome with Hypercalcemia
- Hydration through central venous access
- Rasburicase administration for hyperuricemia
- Treat asymptomatic hypocalcemia only if symptoms develop (tetany, seizures) with calcium gluconate 50-100 mg/kg 2
Monitoring
- Regular calcium monitoring every 1-2 weeks initially, then monthly after stabilization
- Monitor renal function before each bisphosphonate treatment
- Watch for hypocalcemia, especially with denosumab therapy 1
Common Pitfalls to Avoid
- Using diuretics before correcting hypovolemia
- Failing to correct calcium for albumin
- Inadequate hydration before bisphosphonate administration
- Treating laboratory values without addressing the underlying cause
- Delaying treatment of severe hypercalcemia
- Administering bisphosphonates too rapidly 1